Rare Spring Therapeutics Private Limited
About Rare Spring Therapeutics Private Limited
Data last updated:
Rare Spring Therapeutics Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 29 December 2023.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U21002GJ2023PTC147335.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shalin Sanjaykumar Mandhane and Sanjaykumar Nandlalji Mandhane.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vadodara, Gujarat.
Company details
Contact details
Rare Spring Therapeutics Private Limited's registered office is in Vadodara, Gujarat.
- Registered AddressB 79 Pratham Enclave, Main Rd Atladara, Vadodara, Gujarat, India – 390012
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rare Spring Therapeutics Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Rare Spring Therapeutics Private Limited, buy the company report.
Board of directors of Rare Spring Therapeutics Private Limited
Rare Spring Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shalin Sanjaykumar Mandhane | Director | 29 Dec 2023 | 2 Years 10 Months | Current |
| Sanjaykumar Nandlalji Mandhane | Director | 29 Dec 2023 | 2 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Rare Spring Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rare Spring Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rare Spring Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rare Spring Therapeutics Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Sanjaykumar Nandlalji Mandhane was appointed as Director on 29 Dec 2023.
Frequently asked questions
Rare Spring Therapeutics is an active private limited company based in Vadodara, Gujarat, India. The company works in paper and paper products, within the paper industry. It was incorporated on 29 December 2023 (3+ years old) and is registered under CIN U21002GJ2023PTC147335.
Rare Spring Therapeutics has 2 current directors:
- Shalin Sanjaykumar Mandhane - Director
- Sanjaykumar Nandlalji Mandhane - Director
The latest financial statements of Rare Spring Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Rare Spring Therapeutics is U21002GJ2023PTC147335. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rare Spring Therapeutics was incorporated on 29 December 2023, making it 3+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Sanjaykumar Nandlalji Mandhane was appointed as Director on 29 Dec 2023. Shalin Sanjaykumar Mandhane was appointed as Director on 29 Dec 2023.
The registered office of Rare Spring Therapeutics is at B 79 Pratham Enclave, Main Rd Atladara, Vadodara, Gujarat, India – 390012.
Rare Spring Therapeutics operates in the paper industry, in the paper and paper products segment.
Rare Spring Therapeutics can be reached at its registered office: B 79 Pratham Enclave, Main Rd Atladara, Vadodara, Gujarat, India – 390012.
Rare Spring Therapeutics is registered under the jurisdiction of the Registrar of Companies (ROC), Ahmedabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
